Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Marfan Syndrome | 5 | 2020 | 10 | 0.580 |
Why?
|
| Atenolol | 4 | 2020 | 10 | 0.450 |
Why?
|
| Losartan | 4 | 2020 | 68 | 0.440 |
Why?
|
| Aorta | 4 | 2018 | 139 | 0.280 |
Why?
|
| Aortic Diseases | 2 | 2018 | 67 | 0.260 |
Why?
|
| Heart Defects, Congenital | 2 | 2005 | 38 | 0.240 |
Why?
|
| Heart | 1 | 2007 | 191 | 0.230 |
Why?
|
| Warfarin | 1 | 2005 | 35 | 0.230 |
Why?
|
| Anticoagulants | 1 | 2005 | 143 | 0.210 |
Why?
|
| Child, Preschool | 9 | 2020 | 1355 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 352 | 0.190 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 3 | 2020 | 70 | 0.180 |
Why?
|
| Infant | 7 | 2020 | 1123 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2020 | 9 | 0.160 |
Why?
|
| Adolescent | 8 | 2020 | 3805 | 0.160 |
Why?
|
| Child | 7 | 2020 | 2614 | 0.150 |
Why?
|
| Obesity | 1 | 2007 | 1246 | 0.150 |
Why?
|
| Aortic Aneurysm | 2 | 2014 | 14 | 0.140 |
Why?
|
| Coronary Aneurysm | 1 | 1997 | 2 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 526 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 90 | 0.130 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 1997 | 11 | 0.130 |
Why?
|
| Heart Ventricles | 2 | 2015 | 155 | 0.120 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2015 | 9 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 19 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 67 | 0.110 |
Why?
|
| Echocardiography | 3 | 2018 | 202 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 184 | 0.100 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 287 | 0.100 |
Why?
|
| Algorithms | 1 | 2015 | 561 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2015 | 440 | 0.090 |
Why?
|
| Humans | 15 | 2020 | 34562 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 755 | 0.080 |
Why?
|
| Male | 10 | 2020 | 20740 | 0.080 |
Why?
|
| Young Adult | 4 | 2020 | 2831 | 0.080 |
Why?
|
| Adult | 7 | 2020 | 10030 | 0.080 |
Why?
|
| Embolization, Therapeutic | 2 | 2004 | 87 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2018 | 3623 | 0.070 |
Why?
|
| Female | 9 | 2020 | 21532 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2005 | 730 | 0.060 |
Why?
|
| Diastole | 1 | 2007 | 100 | 0.060 |
Why?
|
| Coronary Angiography | 2 | 2004 | 168 | 0.060 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 8 | 0.060 |
Why?
|
| Goals | 1 | 2006 | 36 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 90 | 0.060 |
Why?
|
| Clinical Clerkship | 1 | 2006 | 42 | 0.060 |
Why?
|
| Linear Models | 2 | 2018 | 465 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3825 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2004 | 5 | 0.050 |
Why?
|
| Transposition of Great Vessels | 1 | 2004 | 5 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 31 | 0.050 |
Why?
|
| Pediatrics | 1 | 2006 | 167 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2004 | 41 | 0.050 |
Why?
|
| Balloon Occlusion | 1 | 2004 | 38 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2004 | 50 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2004 | 61 | 0.050 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2004 | 87 | 0.050 |
Why?
|
| Reoperation | 1 | 2004 | 265 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2018 | 1508 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2004 | 850 | 0.040 |
Why?
|
| DNA | 1 | 2020 | 235 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 988 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 744 | 0.040 |
Why?
|
| Dilatation | 1 | 2018 | 9 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 176 | 0.030 |
Why?
|
| Ultrasonography | 2 | 1997 | 417 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 306 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2018 | 149 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 804 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 928 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 379 | 0.030 |
Why?
|
| Aneurysm, Dissecting | 1 | 1995 | 13 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 2367 | 0.030 |
Why?
|
| Esophagus | 1 | 1995 | 30 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 922 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2014 | 28 | 0.030 |
Why?
|
| Arteriovenous Malformations | 1 | 1994 | 9 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1995 | 87 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 1994 | 27 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 354 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1606 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 823 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 4137 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1995 | 1393 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 28 | 0.010 |
Why?
|
| Students, Medical | 1 | 2006 | 136 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 104 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 61 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 2004 | 58 | 0.010 |
Why?
|
| Heart Atria | 1 | 2004 | 84 | 0.010 |
Why?
|
| Radiography | 2 | 1995 | 397 | 0.010 |
Why?
|
| Calcinosis | 1 | 2004 | 150 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2004 | 83 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 323 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2004 | 239 | 0.010 |
Why?
|
| Anisotropy | 1 | 1995 | 13 | 0.010 |
Why?
|
| Elastin | 1 | 1995 | 17 | 0.010 |
Why?
|
| Tunica Media | 1 | 1995 | 41 | 0.010 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1995 | 9 | 0.010 |
Why?
|
| Collagen | 1 | 1995 | 240 | 0.010 |
Why?
|